Evidence map›Paper›PMID 22012809›Full record

Trial reportBMJ (Clinical research ed.)2011

Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial.

Antonella Crescenti, Giovanni Borghi, Elena Bignami, Gaia Bertarelli, Giovanni Landoni, Giuseppina Maria Casiraghi, Alberto Briganti, Francesco Montorsi, Patrizio Rigatti, Alberto Zangrillo

4 registry-linked trialsOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ (Clinical research ed.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 45 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 9 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00670345 phase4completednot on this map

Efficacy of Tranexamic Acid in Reducing Perioperative Bleeding in Patients Undergoing Radical Prostatectomy. A Randomized Controlled Double-blind Study.

TypeinterventionalSponsorUniversità Vita-Salute San RaffaeleRan2008 to 2010ConditionsBleeding, ProstatectomyArmsTranexamic Acid, Placebo
NCT01655641 phase2 / phase3unknown statusnot on this mapstarted 2012, after this paper: background citation

Role of Tranexamic Acid for Reducing Blood Loss in Patients Undergoing Major Gastro-intestinal Surgery

TypeinterventionalSponsorTribhuvan University Teaching Hospital, Institute Of Medicine.Ran2012 to 2014Enrolled118ConditionsGastric Cancer, Pancreatic Cancer, Hepatocellular Cancer, Colon CancerArmsTranexamic acid, Standard of care
NCT01980355 nacompletednot on this mapstarted 2012, after this paper: background citation

The Effect of Tranexamic Acid on Blood Loss and Transfusion Rates in Major Oncologic Surgery

TypeinterventionalSponsorCorewell Health WestRan2012 to 2020Enrolled76ConditionsTranexamic Acid, Cancer, Major SurgeryArmsTranexamic Acid, Placebo
NCT05816668 phase3unknown statusnot on this mapstarted 2023, after this paper: background citation

Tranexamic Acid's Effects in Patients Undergoing Laparoscopic Radical Prostatectomy: a Randomized, Double-blind, Placebo-controlled Trial

TypeinterventionalSponsorInstituto do Cancer do Estado de São PauloRan2023 to 2024Enrolled122ConditionsProstate CancerArmsTranexamic acid, Placebo
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 9 syntheses or guidelines pooled it, 128 citations in OpenAlex.

  1. Tranexamic acid for percutaneous nephrolithotomy.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Systematic review and meta-analysis of the use of tranexamic acid in tonsillectomy.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2013
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Implementation of a Nebulized Tranexamic Acid Protocol for Pediatric Post-Tonsillectomy Hemorrhage: A Quality Improvement Initiative.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
    Article
  15. Article
  16. The impact of tranexamic acid on perioperative outcomes in urological surgeries A systematic review and meta-analysis.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Antonella CrescentiDepartment of Anaesthesia and Intensive Care, Vita-Salute San Raffaele University, Milan 20132, Italy.
Giovanni Borghi
Elena Bignami
Gaia Bertarelli
Giovanni Landoni
Giuseppina Maria Casiraghi
Alberto Briganti
Francesco Montorsi
Patrizio Rigatti
Alberto Zangrillo
Vita-Salute San Raffaele University · ITIRCCS Ospedale San Raffaele · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine the efficacy of intraoperative treatment with low dose tranexamic acid in reducing the rate of perioperative transfusions in patients undergoing radical retropubic prostatectomy.

designDouble blind, parallel group, randomised, placebo controlled trial.

settingOne university hospital in Milan, Italy.

participants200 patients older than 18 years and undergoing radical retropubic prostatectomy agreed to participate in the trial. Exclusion criteria were atrial fibrillation, coronary artery disease treated with drug eluting stent, severe chronic renal failure, congenital or acquired thrombophilia, and known or suspected allergy to tranexamic acid.

interventionsIntravenous infusion of tranexamic acid or equivalent volume of placebo (saline) according to the following protocol: loading dose of 500 mg tranexamic acid 20 minutes before surgery followed by continuous infusion of tranexamic acid at 250 mg/h during surgery.

main outcome measuresPRIMARY OUTCOME: number of patients receiving blood transfusions perioperatively. Secondary outcome: intraoperative blood loss. Six month follow-up to assess long term safety in terms of mortality and thromboembolic events.

resultsAll patients completed treatment and none was lost to follow-up. Patients transfused were 34 (34%) in the tranexamic acid group and 55 (55%) in the control group (absolute reduction in transfusion rate 21% (95% CI 7% to 34%); relative risk of receiving transfusions for patients treated with tranexamic acid 0.62 (0.45 to 0.85); number needed to treat 5 (3 to 14); P = 0.004). At follow-up, no patients died and the occurrence of thromboembolic events did not differ between the two groups.

conclusionsIntraoperative treatment with low dose tranexamic acid is safe and effective in reducing the rate of perioperative blood transfusions in patients undergoing radical retropubic prostatectomy. Trial registration ClinicalTrials.gov identifier NCT00670345.

Indexed as

AdultAntifibrinolytic AgentsBlood Loss, SurgicalBlood TransfusionDouble-Blind MethodFollow-Up StudiesHumansIntraoperative CareMaleProstatectomyTranexamic AcidTreatment OutcomeAntifibrinolytic AgentsTranexamic Acid

Identifiers

PMID22012809
PMCPMC3198510
OpenAlexW2015914990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.